. 2015 Oct 6;10(10):e0139738. doi: 10.1371/journal.pone.0139738

Table 1. Clinical and laboratory features of each AT individual.

Family	Gender	Age (year)	Age at onset (year)	Presenting feature	SARA(score)	ICARS(score)	Bain MRI	α-fetoprotein(ng/ml) ^a	Immunoglobulins
Family	Gender	Age (year)	Age at onset (year)	Presenting feature	SARA(score)	ICARS(score)	Bain MRI	α-fetoprotein(ng/ml) ^a	lgG(g/L) ^b	lgA(g/L) ^c	lgM(g/L) ^d
FAT–1	male	7	2	ataxia, oculocutaneous telangiectasia	14	18	cerebellar atrophy	350	3.68	0.51	1.53
FAT–2	female	10	4	ataxia, oculocutaneous telangiectasia, dysarthria	25	44	cerebellar atrophy	376	2.32	1.03	1.23
FAT–3	male	7	2	ataxia, oculocutaneous telangiectasia	16	22	cerebellar atrophy	183	5.36	1.16	1.77

Note: SARA: Scale for Assessment and Rating of Ataxia.

ICARS: International Co-operative Ataxia Rating Scale.

MRI: Magnetic Resonance Imaging.

^a. Range of blood α-fetoprotein normal value: 0–13.6 ng/ml;

^b. Range of blood IgG normal value: 7.23–16.85 g/L;

^c. Range of blood IgA normal value: 0.69–3.82 g/l;

^d. Range of blood IgM normal value: 0.63–2.77 g/l.